National Comprehensive Cancer Network

About NCCN

NCCN GUIDELINES AND NCCN COMPENDIUM UPDATED

NCCN Flash Update sent May 27, 2014

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pancreatic Adenocarcinoma. These NCCN Guidelines® are currently available as Version 2.2014.

  • For clarification, “nab-paclitaxel” has been changed to “albumin-bound paclitaxel” throughout the guidelines.

 

  • The Discussion section has been updated to reflect the changes in the algorithm. (MS-1)

 

*For your reference, the previous update (Version 1.2014) to the NCCN Guidelines for Pancreatic Adenocarcinoma, distributed on January 6, 2014, is available at the following link: http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf#Page=4

 

 

For the complete updated versions of the NCCN Guidelines, the NCCN Drug & Biologics Compendium (NCCN Compendium®), and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit NCCN.org.

To access the NCCN Biomarkers Compendium®, please visit NCCN.org/biomarkers.

To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.

Free NCCN Guidelines apps iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps